<SEC-DOCUMENT>0001867096-25-000017.txt : 20250110
<SEC-HEADER>0001867096-25-000017.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110071743
ACCESSION NUMBER:		0001867096-25-000017
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250110
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Xeris Biopharma Holdings, Inc.
		CENTRAL INDEX KEY:			0001867096
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				871082097
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40880
		FILM NUMBER:		25520400

	BUSINESS ADDRESS:	
		STREET 1:		1375 WEST FULTON STREET, SUITE 1300
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60607
		BUSINESS PHONE:		844-445-5704

	MAIL ADDRESS:	
		STREET 1:		1375 WEST FULTON STREET, SUITE 1300
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60607
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>xers-20250110.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9c9e256c-99cf-4de8-a7f2-337c74d56d67,g:7c535e41-8b43-404d-b3dc-a5005787239f,d:ac48c4493581448ab9d2e9481bf0ac51-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>xers-20250110</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001867096</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="xers-20250110.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001867096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-10</xbrli:startDate><xbrli:endDate>2025-01-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iac48c4493581448ab9d2e9481bf0ac51_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.984%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">January 10, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">XERIS BIOPHARMA HOLDINGS, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-40880</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">87-1082097</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1375 West Fulton Street,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 1300</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Chicago</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Illinois</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">60607</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">844</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">445-5704</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:4.643%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.683%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">XERS</ix:nonNumeric></span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-21">&#168;</ix:nonNumeric></span></div><div style="margin-top:4.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></div><div style="margin-top:4.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.984%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:4.5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iac48c4493581448ab9d2e9481bf0ac51_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2.02 Results of Operations and Financial Condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 10, 2025, Xeris Biopharma Holdings, Inc. (the &#8220;Company&#8221;) issued a press release announcing certain of its financial preliminary results for the fourth quarter and full year ended December 31, 2024. A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information disclosed pursuant to Item 2.02 in this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="pressreleaseissuedbyxerisb.htm">Press release issued by</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="pressreleaseissuedbyxerisb.htm"> the Company</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="pressreleaseissuedbyxerisb.htm"> dated January </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="pressreleaseissuedbyxerisb.htm">10</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="pressreleaseissuedbyxerisb.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="pressreleaseissuedbyxerisb.htm">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iac48c4493581448ab9d2e9481bf0ac51_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.306%"><tr><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.353%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.456%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: January 10, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Xeris Biopharma Holdings, Inc.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Steven M. Pieper</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Steven M. Pieper</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleaseissuedbyxerisb.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id53d5ee5ce91470eb5acbd8c871d6633_1"></div><div style="min-height:42.48pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Exhibit 99.1</font></div><div style="margin-bottom:6pt;margin-top:6pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:184px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">XERIS EXPECTS TO EXCEED FULL-YEAR 2024 FINANCIAL GUIDANCE</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Full-year 2024 total revenue projected to be $203 million, exceeding previous guidance of $198-$202 million </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Year-end 2024 cash position expected to be over $71 million, generating positive cash flow</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">in the fourth quarter</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Recorlev&#174; net revenue Q4 2024 anticipated to increase by approximately $5 million or 28% sequentially</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">2024 financial results and 2025 outlook expected on March 6, 2025</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%">CHICAGO, IL&#59; January 10, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; Xeris Biopharma Holdings, Inc. (Nasdaq&#58; XERS) today announced it expects to generate total 2024 revenue of $203 million, which will exceed previously announced 2024 total revenue guidance of $198 million to $202 million. The Company also anticipates ending 2024 with over $71 million in cash, cash equivalents, and short-term investments, generating positive cash flow in the fourth quarter. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;We achieved another record quarter of exceptional total revenue growth with revenues expected to be $60 million for the fourth quarter and $203 million for the full year representing growth of 35% and 24%, respectively. These impressive results are driven by accelerating demand for Recorlev and continued strong Gvoke demand,&#8221; said John Shannon, CEO of Xeris. &#8220;Our focus remains on continuing to drive exceptional product revenue growth and advancing our robust pipeline - namely our Phase 3 ready, XP-8121 program. With our commercial engine leading the way and our strong balance sheet, we are well positioned for a transformational 2025.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Other Fourth Quarter 2024 Updates</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Recorlev&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> achieved record number of new starts and referrals.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Gvoke&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> ended the year with approximately 35% market share. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Keveyis&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> maintained a similar number of patients on therapy as Q3 2024.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Beta Bionics, Inc.&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Xeris successfully formulated a unique XeriSol&#174; formulation of glucagon for bi-hormonal pumps and pump systems. This triggered a milestone payment of $3 million in the fourth quarter. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Amgen</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#58; Amgen chose to terminate its exclusive worldwide license agreement with Xeris following a broader company portfolio assessment. Their decision was not related to the performance of the XeriJect&#174; formulation technology. The termination will not have a material impact on Xeris&#8217; outlook. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About Xeris</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Xeris (Nasdaq&#58; XERS) is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products&#58; Recorlev&#174;, for the treatment of endogenous Cushing&#8217;s syndrome&#59; Gvoke&#174;, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia&#59; and Keveyis&#174;, a proven therapy for primary periodic paralysis. Xeris also has a pipeline of development programs led by XP-8121, a Phase 3-ready, once-weekly subcutaneous injection for hypothyroidism, as well as multiple early-stage programs leveraging Xeris&#8217; technology platforms, XeriSol&#174; and XeriJect&#174;, for its partners.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit </font><font style="color:#3051f2;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">www.xerispharma.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, or follow us on </font><font style="color:#3051f2;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">X</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, </font><font style="color:#3051f2;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, or </font><font style="color:#3051f2;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Instagram</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Forward-Looking Statements</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Any statements in this press release other than statements of historical fact are forward-looking statements. Forward-looking statements include, but are not limited to, statements about future expectations, plans and prospects for Xeris Biopharma Holdings, Inc. including statements regarding the financial outlook for 2024, including quarterly product revenue, projections regarding year-end 2024 cash estimates and total revenue, company performance in 2025, the potential for growth of revenue, the market, demand and therapeutic potential of its products and product candidates, the potential utility of its formulation platforms, the advancement of its pipeline (including XP-8121), the impact of the termination of the Amgen license agreement on our outlook, the timing of the release of our financial results and outlook, and other statements containing the words &#8220;will,&#8221; &#8220;would,&#8221; &#8220;continue,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;anticipate&#8221; and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">These forward-looking statements are based on numerous assumptions and assessments made in light of Xeris&#8217; experience and perception of historical trends, current conditions, business strategies, operating environment, future developments, geopolitical factors and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. The various factors that could cause Xeris&#8217; actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements, include, but are not limited to, its financial position and need for financing, including to fund its product development programs or commercialization efforts, whether its products will achieve and maintain market acceptance in a competitive business environment, its reliance on third-party suppliers, including single-source suppliers, its reliance on third parties to conduct clinical trials, the ability of its product candidates to compete successfully with existing and new drugs, and its and collaborators&#8217; ability to protect its intellectual property and proprietary technology. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">No assurance can be given that such expectations will be realized and persons reading this communication are, therefore, cautioned not to place undue reliance on these forward-looking statements. Additional risks and information about potential impacts of financial, operational, economic, competitive, regulatory, governmental, technological, and other factors that may affect Xeris can be found in Xeris&#8217; filings, including those other risk factors identified in the &#8220;Risk Factors&#8221; and &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of Xeris' Annual Report on Form 10-K for the year ended December 31, 2023, and subsequent Quarterly Reports on Form 10-Q,</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> as filed with the Securities and Exchange Commission (SEC)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, the contents of which are not incorporated by reference into, nor do they form part of, this communication. You are encouraged to read our filings with the SEC, available at www.sec.gov and www.xerispharma.com, for a discussion of these and other risks and uncertainties. Forward-looking statements in this communication are based on information available to us, as of the date of this communication and, while we believe our assumptions are reasonable, actual results may differ materially. Subject to any obligations under applicable law, we do not undertake any obligation to update any forward-looking statement whether as a result of new information, future developments or otherwise, or to conform any forward-looking statement to actual results, future events, or to changes in expectations. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Investor Contact</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Allison Wey</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Senior Vice President, Investor Relations and Corporate Communications</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">awey&#64;xerispharma.com</font></div><div><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>xers-20250110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9c9e256c-99cf-4de8-a7f2-337c74d56d67,g:7c535e41-8b43-404d-b3dc-a5005787239f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xers="http://xerispharma.com/20250110" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://xerispharma.com/20250110">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xers-20250110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xers-20250110_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xers-20250110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://xerispharma.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>xers-20250110_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9c9e256c-99cf-4de8-a7f2-337c74d56d67,g:7c535e41-8b43-404d-b3dc-a5005787239f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xerispharma.com/role/Cover" xlink:type="simple" xlink:href="xers-20250110.xsd#Cover"/>
  <link:definitionLink xlink:role="http://xerispharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_7d44e1ef-8ef7-46d4-90a5-59198b547fba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_DocumentInformationTable_7d44e1ef-8ef7-46d4-90a5-59198b547fba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_eb058184-aba3-46f9-86b9-c3d555ef72bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_7d44e1ef-8ef7-46d4-90a5-59198b547fba" xlink:to="loc_dei_DocumentInformationDocumentAxis_eb058184-aba3-46f9-86b9-c3d555ef72bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_eb058184-aba3-46f9-86b9-c3d555ef72bf_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_eb058184-aba3-46f9-86b9-c3d555ef72bf" xlink:to="loc_dei_DocumentDomain_eb058184-aba3-46f9-86b9-c3d555ef72bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_fe85e22b-5b8f-4cea-9332-bc6f3a5de972" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_eb058184-aba3-46f9-86b9-c3d555ef72bf" xlink:to="loc_dei_DocumentDomain_fe85e22b-5b8f-4cea-9332-bc6f3a5de972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8a5a7631-ea96-4f86-a7c9-12c28c12492a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_DocumentType_8a5a7631-ea96-4f86-a7c9-12c28c12492a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a51dce37-0da3-4f64-9666-2787e30edb7b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_DocumentPeriodEndDate_a51dce37-0da3-4f64-9666-2787e30edb7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2df3e357-5ecc-410a-911c-9989046570f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityRegistrantName_2df3e357-5ecc-410a-911c-9989046570f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fed25677-6327-4d3e-b3b6-5c5b97d08f74" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fed25677-6327-4d3e-b3b6-5c5b97d08f74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3433389d-7537-4455-89b1-bc9d1b6b340c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityFileNumber_3433389d-7537-4455-89b1-bc9d1b6b340c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_68b061f7-9663-46d4-af1d-ea845080c42a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityTaxIdentificationNumber_68b061f7-9663-46d4-af1d-ea845080c42a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d4ea70c2-3347-4f6f-8ece-4602af8e1b97" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressAddressLine1_d4ea70c2-3347-4f6f-8ece-4602af8e1b97" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_f29457ff-4680-4dc1-80bd-c92619aa2438" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressAddressLine2_f29457ff-4680-4dc1-80bd-c92619aa2438" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_95444893-4add-473d-bed5-eff766faa4fd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressCityOrTown_95444893-4add-473d-bed5-eff766faa4fd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fc337989-27e0-4f71-8f48-0237b18f65ea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressStateOrProvince_fc337989-27e0-4f71-8f48-0237b18f65ea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3a529397-aca4-49a5-9916-b9fd81f5d93a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressPostalZipCode_3a529397-aca4-49a5-9916-b9fd81f5d93a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_46a30c07-e860-40f9-8cb1-93c82aa8675f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_CityAreaCode_46a30c07-e860-40f9-8cb1-93c82aa8675f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_99e45e79-6490-4955-b271-6bf2662b94ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_LocalPhoneNumber_99e45e79-6490-4955-b271-6bf2662b94ff" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_4a653853-4d6a-4ef0-b389-a648b92f2986" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_WrittenCommunications_4a653853-4d6a-4ef0-b389-a648b92f2986" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a5717a92-9d04-44cc-a549-d6e1975c3273" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_SolicitingMaterial_a5717a92-9d04-44cc-a549-d6e1975c3273" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_98b566ef-83cf-4127-ba11-d291fea8c3f7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_PreCommencementTenderOffer_98b566ef-83cf-4127-ba11-d291fea8c3f7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_b3489eda-c52f-4c8f-b420-43235e4c0520" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_b3489eda-c52f-4c8f-b420-43235e4c0520" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1895fcc9-6975-4125-90a9-f0e96d2ea5c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_Security12bTitle_1895fcc9-6975-4125-90a9-f0e96d2ea5c0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_629cec4f-5438-49ad-bf1a-84a92bd0c12b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_TradingSymbol_629cec4f-5438-49ad-bf1a-84a92bd0c12b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a7489805-401d-4266-af02-6176b6f230e7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_SecurityExchangeName_a7489805-401d-4266-af02-6176b6f230e7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_397ba1c3-ffc5-4ab5-83d5-a755c6bfd6a1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityEmergingGrowthCompany_397ba1c3-ffc5-4ab5-83d5-a755c6bfd6a1" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2f35f940-d22a-4430-aff7-ca63c589ddbb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_AmendmentFlag_2f35f940-d22a-4430-aff7-ca63c589ddbb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_87bea47f-6386-4b20-94d6-07b2b479908b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityCentralIndexKey_87bea47f-6386-4b20-94d6-07b2b479908b" xlink:type="arc" order="22"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>xers-20250110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9c9e256c-99cf-4de8-a7f2-337c74d56d67,g:7c535e41-8b43-404d-b3dc-a5005787239f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentPeriodEndDate_2d423156-f717-49f6-b91f-9c182bf7ab89_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_b9a666b1-1afa-4d51-b65c-369730311521_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ac2b092b-a946-4bd6-a083-bf2a8ebb3690_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1733c99a-fe85-436b-8495-0d2b462831ce_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_63403d68-5519-4e40-ba88-6c5918a5c8f1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cd85f1a8-48d1-40af-8245-13a06897f30f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentDomain_ab4dd6fa-cff7-4dbd-a3e6-97eba58f8b14_terseLabel_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document [Domain]</link:label>
    <link:label id="lab_dei_DocumentDomain_label_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6532b940-4bab-4741-8d4c-f6e4a8e2b05a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3cd60c0a-1431-4d29-bd34-656be414bba9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4ccdb5c1-78d5-4426-b71f-59857326dc85_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c0c89fef-15b4-498d-99af-138815b61afa_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_d5c2cff9-fcb9-40a7-b495-64b0291b2767_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_07717757-301e-4b58-887b-3fde59b6372a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f00407e3-45cf-4f85-b31d-cc08bd57155b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8643f928-6a5f-416e-aa1e-9b062e4198a6_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c8534a11-3b16-4360-bca7-fec859bbaee2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_4346df5a-7136-4fbe-93e1-f0484623c379_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8c7e68a6-4513-467f-ab79-c988ab681d82_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_956e9872-e44b-4f9b-9d6e-5bf4932851be_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_label_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8b23106f-61f7-4f97-b661-b5c0c1b85723_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4b980a4e-086d-4835-b557-55bbf1f91320_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_f75e7a70-940a-4ece-a6ce-fc79c69b8439_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e88dfd26-83cb-48f7-a793-c45592017ace_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9912371a-e337-4af8-97b7-f45bc10ae6f6_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c1e27d27-45e2-4987-a1ea-3f065724a12d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_6de60c04-0d7c-4d54-a4d6-3fd3ee465f9d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5aa13fc0-2fe4-42a3-b196-896bd8e92983_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>xers-20250110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9c9e256c-99cf-4de8-a7f2-337c74d56d67,g:7c535e41-8b43-404d-b3dc-a5005787239f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xerispharma.com/role/Cover" xlink:type="simple" xlink:href="xers-20250110.xsd#Cover"/>
  <link:presentationLink xlink:role="http://xerispharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1484ad3d-168f-4cc9-889a-56c91336eaea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_7d44e1ef-8ef7-46d4-90a5-59198b547fba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1484ad3d-168f-4cc9-889a-56c91336eaea" xlink:to="loc_dei_DocumentInformationTable_7d44e1ef-8ef7-46d4-90a5-59198b547fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_eb058184-aba3-46f9-86b9-c3d555ef72bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_7d44e1ef-8ef7-46d4-90a5-59198b547fba" xlink:to="loc_dei_DocumentInformationDocumentAxis_eb058184-aba3-46f9-86b9-c3d555ef72bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_fe85e22b-5b8f-4cea-9332-bc6f3a5de972" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_eb058184-aba3-46f9-86b9-c3d555ef72bf" xlink:to="loc_dei_DocumentDomain_fe85e22b-5b8f-4cea-9332-bc6f3a5de972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_7d44e1ef-8ef7-46d4-90a5-59198b547fba" xlink:to="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8a5a7631-ea96-4f86-a7c9-12c28c12492a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_DocumentType_8a5a7631-ea96-4f86-a7c9-12c28c12492a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a51dce37-0da3-4f64-9666-2787e30edb7b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_DocumentPeriodEndDate_a51dce37-0da3-4f64-9666-2787e30edb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2df3e357-5ecc-410a-911c-9989046570f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityRegistrantName_2df3e357-5ecc-410a-911c-9989046570f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fed25677-6327-4d3e-b3b6-5c5b97d08f74" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fed25677-6327-4d3e-b3b6-5c5b97d08f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3433389d-7537-4455-89b1-bc9d1b6b340c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityFileNumber_3433389d-7537-4455-89b1-bc9d1b6b340c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_68b061f7-9663-46d4-af1d-ea845080c42a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityTaxIdentificationNumber_68b061f7-9663-46d4-af1d-ea845080c42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d4ea70c2-3347-4f6f-8ece-4602af8e1b97" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressAddressLine1_d4ea70c2-3347-4f6f-8ece-4602af8e1b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_f29457ff-4680-4dc1-80bd-c92619aa2438" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressAddressLine2_f29457ff-4680-4dc1-80bd-c92619aa2438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_95444893-4add-473d-bed5-eff766faa4fd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressCityOrTown_95444893-4add-473d-bed5-eff766faa4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fc337989-27e0-4f71-8f48-0237b18f65ea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressStateOrProvince_fc337989-27e0-4f71-8f48-0237b18f65ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3a529397-aca4-49a5-9916-b9fd81f5d93a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityAddressPostalZipCode_3a529397-aca4-49a5-9916-b9fd81f5d93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_46a30c07-e860-40f9-8cb1-93c82aa8675f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_CityAreaCode_46a30c07-e860-40f9-8cb1-93c82aa8675f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_99e45e79-6490-4955-b271-6bf2662b94ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_LocalPhoneNumber_99e45e79-6490-4955-b271-6bf2662b94ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_4a653853-4d6a-4ef0-b389-a648b92f2986" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_WrittenCommunications_4a653853-4d6a-4ef0-b389-a648b92f2986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a5717a92-9d04-44cc-a549-d6e1975c3273" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_SolicitingMaterial_a5717a92-9d04-44cc-a549-d6e1975c3273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_98b566ef-83cf-4127-ba11-d291fea8c3f7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_PreCommencementTenderOffer_98b566ef-83cf-4127-ba11-d291fea8c3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_b3489eda-c52f-4c8f-b420-43235e4c0520" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_b3489eda-c52f-4c8f-b420-43235e4c0520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1895fcc9-6975-4125-90a9-f0e96d2ea5c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_Security12bTitle_1895fcc9-6975-4125-90a9-f0e96d2ea5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_629cec4f-5438-49ad-bf1a-84a92bd0c12b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_TradingSymbol_629cec4f-5438-49ad-bf1a-84a92bd0c12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a7489805-401d-4266-af02-6176b6f230e7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_SecurityExchangeName_a7489805-401d-4266-af02-6176b6f230e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_397ba1c3-ffc5-4ab5-83d5-a755c6bfd6a1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityEmergingGrowthCompany_397ba1c3-ffc5-4ab5-83d5-a755c6bfd6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2f35f940-d22a-4430-aff7-ca63c589ddbb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_AmendmentFlag_2f35f940-d22a-4430-aff7-ca63c589ddbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_87bea47f-6386-4b20-94d6-07b2b479908b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_38dcc314-1aa8-422c-bf7e-6f97d27d1508" xlink:to="loc_dei_EntityCentralIndexKey_87bea47f-6386-4b20-94d6-07b2b479908b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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M    0 S >$7!W/2\5%R73MN?W(%8>P   " L,%Y18+^'L8X.CAU3+PP
MC\!XA<=1:%>IYJ;GU<L#    P!<P7N%I=DIJ,^W:M$>]/     !\ >,5&)_3
M79DPZ04   "$ L8K,'ZBNXI"I!<    0"ABOD"PNW.'&R+6>?WR[F@\
M> '&*R3^UQDS8;41    " *,5T@.CAWCKLB#R/"I60$   " >V"\0N(_P"O3
MQ-83:E8     X!X8KY#X/$BB*#)\:E8     X!X8KY!P2^1',%X   ! $&"\
M0L(MD1_!> $   !!@/$*";=$?@3C!0    0!QBLDB/$"    >@6,5TBPJQ$
M  #H%3!>(0EUCM>I%]]5LP(     ]\!XA234R?77SGVA9@4     [H'Q"@G>
MU0@   #T"ABOP.S:M(=[(Z<Z.'9,S00     O #C%1C_JXU89P0   !" >,5
M'I^'2N @"0   " @,%[A\3GI=?G49^KE 0   . +&*\H\'.@%Z*[    @+#
M>$7!W/3\LX]MXU9)4,\_OGUQX8YZ80    !X!,8K%IPN.)*K0TP]    $!P8
MKXAPY[W.'[JH7@P     WH'QB@MQ[_7L8]O@N@   (!(@/&*#O)>4O%>SS^^
M'2N,    0#S >,7(W/2\_3['?9L/()H>    B H8KW@YNWNRV=FJ9-IP7A<
M   0(3!>L4/VJ^;[')]];-N^S0=@N0   (!H@?%J!XL+=\X?NCBQ]<3XTSM)
MVY_<D<ULD<B6T=_AMP   (#X@?$"     / $C!<     @"=@O       / 'C
M!0    #@"1@O      !/P'@!     '@"Q@L     P!,P7E%P=&[NN2O3SUSZ
M^/M_?#]3\H??KW_KS>R_GS@WN67JT]TS-SZYLZA^$P    #M <8K&+,K*R]<
MOT:FBCQ6?3WRSLFG+YPG$Z8F!P     [KIW[XO*IST8J>Q6R\N'2]R/3'XN?
MF9N>A_$*P-&Y.3)/W%09B1S8,Y<^/G/KEIHZ     !HQ_O1._D8^KLMK;XM1
M/GSJQ7?5Y-+TX-BQXF<FMIZ \?(*6:YL&5%0Y,">NS*-54@   # $AOCM?W)
M'6IR:?K\X]N+GX'Q\L?LRHK]+%>UR-*]</T:74B]-@    !J<';W)'FC7+EA
M(H]5_/O<]'S*C!<I^WO.M7-?*!^ \?+$[ID;Z]]ZDULE1WKBW"2"P     !+
MBH9)_;<RXT6^K?B!HG6#\?+',Y<^YM[(@\CJ/7WA_-&Y.35#     *B!J?':
MM6E/\0/;G]R1_?W9Q[;!>/E@=F7%=-.B"R$,'P   &A 3>.5&RQ2OK=Q;GH^
M^\OSCV_//PGCY1!R78^^=YK;H("B_" ,'P   *A)3>-%_[%KTY[LO_/5QE,O
MOIO]Y>#8,1@OYT3HNHI"&#X    PDOK&B_Q6]M_[-A_(_C6?!KMV[@L8+^>X
MWL H)9S%"@   .BH;[P6%^YD__WL8]O2;ZXS%C\)X^6$+5.?<HL3L[(P? 2!
M 0   $7J&R_ZO_EJX_E#%XOKC,5/PGC)<W1NCCN;MNB1=TZ2:\02)    ) :
M&J_B:F-QG;'X21@O8<BRD'?AAJ9=6O_6F\]<^ACV"P  0,\Q,E[%U<;\/Y1/
MPG@)T[I%Q@J1_:*?H_Y"    0(ZYZ7GE_=/9%%$D&!FOM+#:F"D/M(?Q<L(G
M=Q:Y?6F['GWO-&*_   10CWT^4,7)];>WY)MUZ]6%FHCR^+"'<4T&"DJA^&.
M["YEK^(A7T)E43SUJEK//K8M*[ZLH"D=Y9T\KLES4M-XY:N-F:B**I^$\9*D
M+3L93;7^K3=?N'Y-_;4 Q$W>(V;M-8GWQ%GKGYUMJ"C_5I:(FCKP#A5H9K.H
M=/)U'"/E7:,@5#?XA>K+198B(7OTR&8IKXB6TOB:DR:7X]J\YE>L:;SRU<:Q
MPCIC\9,P7F+,KJQPRU*N-XXG1PX]\OMC#Q\Y_,BA@Z3UO_MM\IO=&P^\EOU?
M^OO&HX>38X?O?I)_/9">N?2Q^IL!B(9LM2(?3_-FVE[9R)O:^E,OO@LKY@WJ
M5NF>UY\@J9 +EP/C580>0WHZE+4V#Z)GDRY*EW9APO*KU#1>Q3_FZXS%/\)X
MB3$ZNNOXD0U'#I&[(H]57QM>V__@L2/)[X^IJ870TQ?.JS\;@'!0(YNU\HZ&
MU".5^;!\*:$#Y/-\S:0F9P$5+G5:S6:V='+A<F"\TC_Y+1%S;"^J,U1SZ*G,
MW]L3(3!>,F@W,[YQ?-W1P]F<EHTV'CQ Z:B)>Q>\%PA+MMXDWB7;B_S?V=V3
M,;?U=>"_RTAJ<N;0#:0NW)&3=N%R>FZ\J,X[FF 64;1/)8R7 &=NW>(>A;3^
MR*%U>_=P%]589.""VZ_GKDRKOQ\ ]Y#?\K^$T4!96Z_FOB7PGV,D-3D3YJ;G
M7?MI%RZGG\:+K,S$UA-."TM0V1Q85.$!,%X"/'/I8]6@'!.8Y=)IX\$#R?$C
MZA4]RMM;AL0[6AI,J]=H/Y9-/U?V@HM(H/[XX-BQMC3QN2C#E&W/VZ_LX3_$
M2&IR]<@L%T]-7"Y<CN73YR)+3FF7Y5)$+1ME/H8),!@O =:_]>8]7_+&\0U'
M#G&W)*[U=!5FB?R(?N\G=Q;5N^  >D+$GW 7T9<!H5LDOBX3R="0LA'S*D9-
MD:5HD?WB^3>2FMPHLEZ<I^-(+EQ.?XQ7JRV7(GHJPW8$,%ZV[)ZY<<^4'#^R
MX;7]W"0YTH;7#X3:^?C]/[ZOW@@WG#]TD3\V-MK^Y [U&FWFX-@Q_AMMY.*L
M(U.Z8;F*:HO]XCDWDII<)6=W3WKNQ5VXG)X8+VJ'Q0=XP44W/]0@$\;+EGO'
M=QT_(AO154=W?5Z@9<?V+CC*;K\*B&6CSQ7<E=(PM&.6JZA(ECDJX'DVDIJ<
M!O*@04K9A<NQ? 9=9$D6JK'B+7!4"F*_8+RLN'=\5PC7E>GN=8\%B+A_Y)V3
MZNUP@XO5M+#SS")T;!V6?H[X[%V$HIH<\_$3/,-&4I,KX]2+[XK7VYIRX7*Z
M;;SHUX4J+,_R;+]@O*QXX?JUNRXDG.O*%62WH[<=CI:M&U?PJ1U[Q(>A 2<"
MR8OTI'W/M&_S@3BGOGA6C:0F]TWH)P>9Z,KEPN58-DTNLB2%S_"[2$2-JI^0
M !@O*YXX-QF#Z\KT9X=>Y][(J;Q->J4=#69JC'CH6Z@.@#IC/SO:8M/SCV\/
M.+^H@^?32&IR!>C'!O?6+BIY)XU7YY<7J^4A) #&JSEWWXK]QG&?T?0CY3_<
MWMMK'.E)$#\9V>?<LB#BBXR4FI]QG@)UQN)EVB[%=N(7SZ&1U.3^A/+:X%!R
MX7*Z9[Q<M+2MD^N0 !BOYCQW9?JNT6'N)ZSNGA_F,=S^B7/^>@[JI_D38B-Z
MNER/;%P@/A@-<KR9_TUM<2JJF5>>/2.IR:T1SXRF"Y?3,>,%UU44M;2..@@8
MK^9\Y^CA=2^__!>_V?T7+[^\<>=+R2]_J>B15UYY^)57'MFS)]FY,]G]"C=)
MCK1N[Y[[CQ_E)LF19E=6U%OC#/&P@ZBZO3J(3QY0XZ)>PSUD]7A.>JOBFW3#
MPO-F)"6UV-:17;B<+ADON"XN&ARZF/J"\3)F9KAR<G#K_USYD#NM:FUXZ:4'
MR7Z]\C*W2BYTW^&#W"2YD+?5Q@SQIJ%%"XYST_.RLT24FJ,A7051=<:1*!+O
MQ3-FI&)2$?;B+EQ.9XQ7A.45C\1WP\!X&7!A=?'5Y=D7EK[\^:WI_W+X=]Q:
MU=3#K[R2[-K)K9*X_(3;>WYSMGB4;HL6',4WA;D8S%4#UZ53#-Z+Y\I(>3IQ
M]N(N7$YGC%>$Y165J)L0'*+#>-6"+-?.Y1FR7*1?W+[ZK4MO/_C2K[FC,M)&
M\E[N[=>?O;;?=;B]S[V-&>(+53'T>2,1_]7^%QGANJH5O![R+!DI2R1.US7F
MQN5TPWCAP:PIJ3-W8+Q&,#-<V;\\EUDNTM;%Z]^9>B]Y_S@W4LVT\96778=_
M>0BW]QGFE=&!N1\CQ!<9_<_SH7&O(ZF6O1D\/T9*(W9=8VY<3@>,EWC8:+=%
MU=O^(!@8+RU+Z?#DX%9NN3)][_/)Y.);&U_?QRU48]VW8X?KJ2_7X?9'Y^;4
MV^<8<2,2)-JI/N)&4W#:O YHW.LKX!D3/#-&2AULN164"Y?3=N,EWI#6%_UV
M$HW':+#!=7#L6/:!4-FKD/V6+!BO<BZL+HXOW5!<UX^NGR?715HW/L[]DZ76
MO^P\Z-Y=N+WG^/H,\4-$_2^]U41\D=&^X3!"O*1L]/SCV[,&7:?@$S;4T]@/
MJ9O!,V,DGY.:=)?H@:4>FFJ7YU%$D;8;KW'I$9U.]-Q1]:"FC.Y8@R$N?8L&
M)%3<WC*LD\A: 8R7RM75Y2R"7M&/9R]EKBLY>8C;)A']V:Y=W"W)RE&X_9:I
M3]7[Z 7QX76$"X[BIY>1L;!O..H3:DA-[6/6,5-[3:UV@Q-BZ2OT1>HJLL&W
MSU\ATK@W@.<D-E'MI1()94PYK39>'D9$] S2 ]C@Z:N&*@!5 _'VOXY$7#Z,
MUSV6TN'$R@*W7"^L;6/\VG5=?.OA@[_EGDE*/KR7@W#[4,9KT<$9[D$ZO K$
M)V \=UKB^:\078N<5K,A=1U\-O=! NUY-B(1/9AD?\7[;WM:;;S(W_,LB8B>
M1/);CAY#!;*/]+#(=@0Z2:T5P'A]S>3@*[ZVF"G;QOBU\?KP3>Z69.7!>XF'
MVX<R7JEUP\<5U8*C^(&QGF.WQ=^P6:IL5.VGE<^AYMZU _,__\KS$%QD#@(&
MO8W$LOT):+S$VY9,](M$YH0:D#DPGB4I"<Y#PWAIUQ8S?;V-\4_37>M.'.16
M25P;W!^R>O_>/>N.'N86JID"&J_40>\>Y!4Z'!>+C.HU7&+9)XT4M8,3[E]G
M6\W<]#SEP=%HV__\*\]#0-'/C^1)K,"RD@<T7N+37=2\A+)<1>B1H6HC_NO&
MA!89,WIMO&X.![JUQ5S9-L9<&_?^AOLD%[K?O?<BK3]RB+NH!@IKO.A)DWW,
MG@WTTF@%V44ZSS]*O%"*BFT6A'ZL(_LEM;11$YZ!4!(_*]P1+35>LKN,X[3(
MYP]=%(S$EWT2^VN\S@QNZ]86<^7;&+_6Y 1W2(ZT;L<./R\7NAMN;QWR]=R5
M:?7^^D5\<BA4@YC3]FD\\?QGHB;>\VII?<C7"C;TN7S&Y/&K^Y?L$>&N::GQ
M$AS4B9QKY0XJ(/NG4G"1,:./QNOJZG)^#'V%[FUC_),>?,/'.F.N#3O='NZ5
MRS[<WO\Y7ASQD 7/3J6(96O.Y;E]%_?!F>A7^)RT:X;XV1\^RXY?W;-V;=HC
MV\.YQO)1]5FX.8*/)^6_%>5E:;_$1P+],EXWAX/#*_/<8W$5MS'FVK![%[='
M3N5GP9%TW]X]-N'VG]Q95.]U" 2'<6/>U^9RQ!?I_(<*V;1Q.D4[T<41?YVH
M>+NO@U_:IP(.=1K31N,E-1L=9..M#></76S0M,HN,F;TR'C565O,M'7Q^@/Y
M-L9<<J\)JJ_UO_J5ZQ<*Y;()MU?O=2#$.SS/T>@94LUB+L^;XUP<#A151%<=
M9*NBM^Z97]J/Z%YYKJ52M-%XB0Q0@[2-(AB%8XHO,F;TPGA=7EVJL[:8NZ[B
M-L9[TUU'?L>-D0=Y.-&^J ;A]M__X_OJ'0^'^$*/YXD6RW:<R__I& W&E-5J
MG>O*D/5>?B:]^'4]Z-EP)_7;8_G ^C=><]/S/!NF\C^)+DO]<$Q'SUW'C=?-
MX:#XBNLZ^L'5#[CK(CWXTJ^Y*_*@^\?'_439YS(-MP^[I9%3\XFJ+V^]@O@B
MHZ/A6@6RNZ7&6NNZ,@2]EY\>FE_7M5KMNM(6&B^1)[2ETY,*-$JO?CQ=+#)F
M=-9X+:7#,X/;W%=5ZZDO/^*6ZZY"K#/FVN#^2%5%1N'V9V[=4N]^4,3?4>-M
M4EW\]#]'P[4*9(VCY^E&%XCT<YD\1!SRBSI5VUU7VD+C91_)X#_/[J#JIUMX
M=3IJ[:;Q,EI;S,6W,>8*M<YX3[L\[7#,53/<_I%W3JIW/P+$PXP\. #Q/+L;
MKNF0_0F=:=^E_+2' N47=:<.N*ZTA<;+?D' _W#.-:5FU.G/[)KQFAFNF*XM
M9OKYK>E[[P5BVKC[9=4)^=7=*'OFC5RK3KA];.N,.>*O<W':22Q*OW1RN]\W
M86?8M^FYG@VTI=0%4H5+B:A)2\,OZDY.'RAOM,YX659%;]/_GJ%R+-X9UX.<
M[ABOI71X<G"+.ZHZ*M_&F,O]^QGKR'.4?:[J</M(#I+@2/5VN9Q:F7;9Q%($
M#P<::^?) A5(+3BZCJWA5W2D5H?N%6F=\>)Y,)*'N?]04/.>M<-.%QDS.F*\
M+JPNUCPJ@DNWC?&>3A_A-LB__$?9Y]IPL#S<_M'W3JLE$1.R*U]CSH9!XOD,
MTCA*+:B-K35\:NKM1V0ZT/7)2?R*+N3H.0I"NXR7_99&IPMP,4!#/@^_L?7&
MJ_':8B[=-L9<&X\?X#8HB/Q'V>>Z&V[_^V.*\0K^IJ"1E"[>VTC\F70Q,Z=>
MPSVROT+\)L> B+UVO=K(KR@NSU;#->TR7I:Y):DI@D:TV'C9K"WFTFYC+.B1
MWWM]4] (>8^RS[6.A=O/KJRHI1(9\1_0(+O(&"I@66HI;<Q[5^03D:KH=+61
M7TY6S[;\_">.I97Q7-LM<SL&XR5$6XW7Y."KQFN+N2JV,1;U%WM_H[J?<-KP
MTDO<$OE4'F[_Q+EV1&G8MS6*!!=*Q(][#14:)6@?.Q/]PQ$I;L'JQ^&7DY53
MUQ@$R^8%QJN?M,]X75U=?G5YEKLH4U5O8RSJD;U[N $*J/O"+3AFVK 6;O_"
M]6MJV<2*^/NS1=;"Q,\;\]R(YRPNW.&9::9.1G?EB-PHITO)_'*"<FH90V%I
M93P_LY:Y'8/Q$J)-QFLI'4ZL+' +U4 CMC'&;;S6[=CA[06..CUR[,CUY26U
MA")&=TI>,XDL.(I$6^<*>/Z"X#ICD&T!/A&9&K2O>SKXM:0D\LA$B*65@?'J
M)ZTQ7B)KBYE&;V.,VWB1-@;:WICK!R?_,#Y_97XU]ABO'-G##L:LWX$HLNI4
M5,!%'!$SD2F4=_2&B$EU5];\6E)RE^>P6%J9UADOD<E^T +C=75UN<$Q]!4:
MN8TQ?N-U5^&B[$G_?.']?_M_GVZ;G?IBT)IYKWB\CO@BHZ4+M(3GIYF<+J)%
M@OU^_C&7\X+\6B+R;"]\8FEE/-\9^^KGKN[UBJB-U\WAX/#*/'=.-OK'F8O<
M6E7KX8._54U/! H89?_0@?WDNG)]L'13+;E8$5_=:[9Z(KONV3@;(EAV/$6%
MVAG@&?N]C>YZ:WXM$75X(M.R_KLK2AT\#T;J=A2F-^(U7F<&MZ76%G/]9/XR
M]U4C%==Q$@6M"W26_0_?.5$T7J3CMV?4\HN2&*::XHST;XS@26E!#L+PC_W*
MK+O3O/BU[-7)F/J<UADO^P:PP_N.O1&C\1)?6\Q4?QNCHG4G(C5>]P6*LO_I
MU#G%>)'VWOSBSG!5+<OX$ FR*<IHP5$\U"QXKR8U>]>?D;2(\W8TQ\DO9*FP
MT[$>:)WQLI_U[WR9>B NX^5B;3'3UL7K#WUZFINJ6HKCE4&EVN ]RO[/7_O&
M.F-1;0FWMY]R*,IH.Z&43<D4PTXQGJMF<OTRG'BP[*HS.9KFY!>R5.=#@BQ+
MT[_Q$IFB;C#3#XK$8KR6TN&9P6UNF*1DM(VQ1,SQ1*27O1[K]??_>9I;KES;
M9J<^6XGTM=DYLN^W&:O=>HI,=105?&W.LM<IJB<!7JG0K*?1/&M]^(5LU(>I
M$<M'H&;3(8C4E']_1DHNB,)X75Y=<K&VF,MT&R-75(?7*]KH=WOCEBL?<;^E
M*/YP>Y$7YQ4UTC>(=+=%Q3"7(&@E@YM(G_"?;RI'I<\O9*,^],VM,U[V&QMS
M]:%\'1'8>-T<#BQ?<3U2#;8Q<CWX1J1A7IF\1=E_^_!!;K-*]?JM&VIA1X;(
ME'NNZ@5'&O?++C)&<O*"X**MFG2GX3_?5*TP7A5/1&=HG?%*10,>*/^=G]1T
M03#CY7IM,5.S;8PEFIS@=B<>>8NR_Z=S9[C'TFG7PK68P^T7I=^?7=&&BIN\
M2.:'I&Y@)#[2&_8!SA65S09^H<;J21A0&XV7[(F&U!PY6OCN,&&,UX751?&C
M(K@:;V,LU<:(5QL37U'V__K%Q]Q@56A\_DK,)ZQ:-II<I0N.?J[B'Y$W#V;J
MVYI%'XQ73SICRZ?;43E6([C:F(M\=A\F.*7P;;QFABNNUQ8S66UC+%.TATK<
MDV/O];T__)Y;JY&*/-Q>,$IIK&PNRN>\FF<LNYRB'"V<14OGC5=_#@>Q? H<
ME>-([&L@%[5^]"!CY;$._HS74CH\.;C%'9(CV6YC+-/ZEWZM>IV8M&&GVRA[
MHW5&13&'VPM&/(RQ53/Q1<9XAI52VZ/&>C,[DF/?[3E:G.47:J;@Q\MYHZ7&
MRS+;%8+]JH,GX^5G;3&7_3;&4L4_Z76_LTFO!_;MY7;*2-&&V[O;;RC>ND5E
M4 0G"QV=2A4M]L9KS,UV!'Z59HIG>. :RV<\E/%*A2IAA?9M/A!)*&J$.#=>
M5U>7_:PMYA+9QJA3Y)->ZW_U*T=1]C\X^0?NI4Q%WBO.<'M!#Y&)6ASQ1<;8
MHI4%&^Z^C8]%;IV:J 3\*@WD:#8N3MIKO"QS7E-4&<[NGNS; SX2A\9K*1U.
MK"QP8^148ML8=8KX%/M,Z]T<+?'/%][G1JJ!QN>OJ!4E#D3ZPES4W @>M3 6
MY5F4@G=,3;KKB-PZ-5$)^%4:J%<1>Y;V):#Q2D6/@ZD6-5_[-A^(:L(^+*Z,
MU^3@*Y]KBYEDMS'JM.'([[C=B4O2"XX/'="^)JB!XEQS%']_MJPB;+-X)AM+
M3;KK=-MX]6J!J=7&RW^C1Y<[.':L5S6D%'GC=75U^=7E6>Z*7&OKXO7O.@BH
M+]&';V[8O4OU.C%)/,K^A^^<X/[)1L=OSZCU)@)DC[<15)RARCR?S12V[PE"
MAXT7]:QJHIVFU<8K=? .CYKJ^1R8I/&Z.1SX7UO,]>AG9U6'Y$[O'U\W/LX=
M3T02?8_03Z?.<?-DJ8O+M]4*% '>YM[K*X8W87,$=R0$[WO\TV'CU;<CV=IN
MO @J,IXQ;R('1JUNW^+ Q(S7F<%M_VN+N1QM8ZQ2W,%>=Z/LF7]JIOJO"3+2
MMMFI" /MQ=^?;:\X=_Q9]C=%Q=#W>*;#QBN2TWV]8?D@1%+Y12JDO;8_N6-B
MZXD^+$0*&*^KJ\M.7W$]4C^>O:2Z(B^*_'0)J2C[O__/T]PVB6COS1@?L%!S
M[Z6*-D[9LK\I*I*^QR<B_9R:J 3\*J;J0Z]9Q/)!B*3RB[],UE+Y-%A7SR6Q
M,EXWAX/#*_/<"?G4SQ:FN"7RIIB]U_WCXR)1]J:O"3)2G(?:AYU[SQ7SMGS!
M>+@X(]B<TF'CI:;8=;IAO-+XO%>NYQ_?3DU$QZ+!FANOL&N+F?QL8QRA]X_?
M]Q^1QGMMV+6+&RDC_>U;;W"W)*A="]?4BA4!XD=P-5/,DP>")Y]%.ZOGCJX:
MKWALA#<Z8[S2B+U7KEV;]M"0KP/38$V,U^75I;!KBYG\;6,<J0_?W+!W-_<]
M4<@NRG[+E8^X6Y)5G)->ENVIO2*/E8'QLJ&KQJMOD?6I=4,1E?%*U[Q7A!N,
MN+)IL#CC7^M@9KQN#@>>CZ&OD-=MC#6T_OC^^__C/U3?$UHV4?:NI[LRQ3GI
ME4J_9M%(L37''$'C1;TU-:"]DLB\@EHD$O"K&*F''OIRMXQ7AN#3[5HM/9:B
MKO%:2H=G!K>Y^PFE -L8ZVAR8N/K^[C[":MF4?8/[-OC-+JKJ/G5%;7"Q8%(
M!VFJJ-Z$K2.@*X4RJ44B ;^*D2ZW=@:B,9TT7NG:[XIM?W>UVN7 :AFOF>%*
M#&N+N4)M8ZRKR.S7NAT[&KS \5\NG.4.R9'.W(G49PB>5E5?9W=/JOF(#Y'%
M,LA&:I%(P*]B)!@O4T5KO-+V+#LJRAQ8S &R:1WC-3GXBEN?@ J[C=% '[[Y
MX!L'(SGC?J/A]L:_\;+(F"O:%SBFWF?=8WL3M@X8K^!2BT0"?A4CQ3]3*TZ'
MC5?&^4,78]AIU$"4[5,OOAOGN:PCC%? D^A+M77Q^@/!MS&:ZOWC&X[\[L&7
M?LW]D%?5CK+_]N'7O2TRYHKP,-4<;R8CPC=AZ_!V3R"=U"*1@%_%2&IR/:#S
MQBM=F_KR//Z458038%7&*S;71?K>YY.JK6F13A]Y^.!O0[UK:,-++W&/Q?7
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M7QNO.#<S9N*. 9+2/UV+)=(KVG.\/)Q97U1;7I+M^;9 7&J12,"O8B0UN1X
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M":,L4<;HAM3O#]0D',,S8"0UN1Y@:7$</9B>'[KG']].%3O4Z(Y#A3)R2--
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ML[/\O*[]RW,X$Q4    (BS_C=7,XZ'F4?:Z?+4PY.FGB@4MO\^5%O/P'
MB 1_QBM%E/TW10[IH4]/<_/43-^Z]/937W[$)[JPM@@   #$@U?CE2+*GFG3
MW*=__?DD-U+U]=VI]\C#<<N%M44    @-GP;K\NK2]Q\0&2;R#R1 ZN_\_%O
MKDP^?>/C7]R^RE,C=TOW6;WU      B-;^-%[%^>XUX!RD5>ZF<+4W_WY<5_
M6!.YL;^:/IO]-VG3W*?5KUP\,[B-M44    @3@(8KYO# ;<+D+W(T>(5UP
M $#,!#!>*:+LI86U10   * 5A#%>2^D04?8B&E^Z02Y6O;\     B)(PQBM%
ME+V$#J_,8VT1    :!'!C%>**'L+[5R>P2NN 0  @-81TG@ARKZ!L+8(
MM)>0QHLX.;C%O06DT\3* M86 0  @/82V'@MI4.\P+&.7EV>Q=HB    T'8"
M&R_BPNHB]QE0+C*FDX.OU+L&@ ,^N7GSZ-6KI.<^^&#+>^_1_V;_E_ZN?A0
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M2>J5N*ZF^8]:T^6D9IW/X%\W3<$#I6'UV1E7_.\UYUU\PC.9U*MLY+WX%Y-
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M"L];4EG9J-NF7\1[]%Q.M\[IT-4W^GOIS%RQ%O'?DCTO/+6D\LYXHW0:M71
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;O@   %#X_Y5M,JLD:F(+     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46034445302768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 10, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 10,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XERIS BIOPHARMA HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-1082097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1375 West Fulton Street,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chicago<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">445-5704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XERS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001867096<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #4Z*EK%@7X)[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #4Z
M*EJ97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ -3HJ6LT5OEQN!   /A$  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #4Z
M*EJ?H!OPL0(  .(,   -              "  ;(,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ -3HJ6I>*NQS     $P(   L              ( !C@\
M %]R96QS+RYR96QS4$L! A0#%     @ -3HJ6JK$(A8S 0  (@(   \
M         ( !=Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #4Z*EHD
M'INBK0   /@!   :              "  =<1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( #4Z*EIED'F2&0$  ,\#   3
M      "  ;P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
'  84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="xers-20250110.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xerispharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="xers-20250110.htm">xers-20250110.htm</File>
    <File>xers-20250110.xsd</File>
    <File>xers-20250110_def.xml</File>
    <File>xers-20250110_lab.xml</File>
    <File>xers-20250110_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "xers-20250110.htm": {
   "nsprefix": "xers",
   "nsuri": "http://xerispharma.com/20250110",
   "dts": {
    "inline": {
     "local": [
      "xers-20250110.htm"
     ]
    },
    "schema": {
     "local": [
      "xers-20250110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "xers-20250110_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "xers-20250110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xers-20250110_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 28,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://xerispharma.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xers-20250110.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xers-20250110.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document [Domain]",
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information, Document [Axis]",
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xerispharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001867096-25-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001867096-25-000017-xbrl.zip
M4$L#!!0    ( #4Z*EK #-#\CP\  "$^   >    <')E<W-R96QE87-E:7-S
M=65D8GEX97)I<V(N:'1M[5MK<]LV%OV^OP*;I*\92K7\2!P[FQG7<5JWV::-
MVTWZ:0<B(0DU"3  *%G]]7ON!4A1LNSLHW&RG7HFL43B>1_G/OUD%JKRZ9.9
MDL73OSSYZV @GMF\J90)(G=*!E6(QFLS%:\+Y2_%8)!&G=IZZ?1T%L3NSNZ!
M>&W=I9[+^#[H4*JG[3I/OHS?GWS)FSP9VV+Y]$FAYT(7?[NGBX.]XD"I@UP]
M'NT_VE'C YF/B\/\\-&H>/AP;^^?HWN8BN%QC@_+4OWM7J7-8*9H_Z/]W>'^
M81V.%[H(LZ/1SLXG]]:'2C?%Z+$-P59'.\-1'3!@8DW 61S6CA_C%M<W6IO]
M$/ND)\'6_#6HJS"0I9Z:(Z9'6KN=G]O2NJ/[._QS3&\&$UGI<GGTV8G3LOPL
M\]+X@5=.3^)KKW]31R.<,GY=Q%L^PNQ2&]7>>K2WAWN>7<WT6 ?Q^/%PM'Z1
M_^ *.+&NID*6 >RHY%3]<T<.?ZVG]X1W^;5'<<UTBH>[]=7Q^OH'6'^N7-"Y
M+!-=F$3Q=<NEP_WZ:AM?>]3,(3O*W14Y1[L@YYNS5^<7XNS-#V>G/UV(GU[B
MX^G9V3/Q_.<7+P:_G)V\(F'?%\_/OS_Y_O3\Y(7X^N?S9_AX=HWV-PK8.][=
M&1UXG2,=L$>^1IG]K91YWI3E8*FDBQ0(%A.%4W-E&B5J9W]5.4%%L&*LQ(/=
MG3V!PY3:FDRHJURI@B"DQ@1M&R^FC2ZDR96P$_%@]/AP@!F[[0SQAR#8+Z#5
M0)DBTBN7?B9JZW6@"ZJKND\N"W41#QZ-5B2;*J.<#$PSGC17<8E):1?_-R30
M1H29$A/;N# 3;QOI<*8_!'-?J=RZ4LT_O3]ZM'\LC J=+ORX'SDN#1!0US*Q
M61NRIEZ)\5+(&@IS!5@-JER*!P>=X%MHU^$GPJNW#6Z)<Y?+/P2YF" 3;:#R
MFF'#-V7P(%$1G0?;A-+:RY5>@!9_ERZ?B8<9C_A?J?!KXX.>+._,EAS@TJ??
MG)^>?/TR$^<O/KU_\/A8?"L-5& I1COKEWH?1[K.!SJ2^/3^X>YH="S>8+X7
M7VE;SZ2KI/C&E@30'H<U^5!\_KWTA7R+8Q]B[-FKBR\@PH6$Y!IC&^!V(>!S
M1&YYDNZ$5RK9!>9WJQ $\6OV8#'3X.P"7Y-IZ.Q"V=]ABYW9-!N=XN (?0LR
M%#\!=TYM54N#)4MO>^KH!5"9D)4W6&A TR8 0UL9;K,(NE!'N+8E- D$(J'U
M,^O" 'I58>1<^5#%=[?"MM@*A\/_V=J]7]G>+D@D1[L[QZ^5D/E,@SL%Z&)Q
M.P=> 1J+]GK$*6)R378/G-S@I[.+,(L\2,_\IG%\\'"G8\L$ 'F=A,R2OHBM
MQL%I$>RT. 49\P2JX$W:%D?;._@DHM#^)QG!$NT,II5+EB"@M:YHGB=&=JCE
ME"@<GAC&\CQ79<OT0E6T&FW?6@A>/K>T<8,[^> L!GX]MY<J#<^8F%!*+W4A
MOK4S(RYFI 90E=.SEW1,5M>A2%1_V3ALD<.-<EA &T]PF;:@4X!N?+XUPL/B
M%$T>-DE/IY/%G( 9,T%6X>P8 B5J72OBNQ@((RNR4_3RAQF9L#VL(HME)M[\
M,#@<[8YH\:F3U5"\9FW"P-Q6E7*,]LI,:9T24_ATX,N"H:3@D8DB8UFR9ON9
M4@$8H9C."P4&MFZ3BI25(CB(+C["@,;+$9H.$QD_;G7:;BI>LN8\CU+]8Y)J
MAJ>?ZX(@Z\:#U[(@J@Y*-0E'>QOA:+I*?*1- ?$_&HP.Z_<5HMZ"%0^/WZ>U
MVT;5XS72C/:'HP.Z^+KG]@%,< >8"2A-4XTC3AJUP!G _.@9.351SL%X#?_D
M_N_%?<;=#\9Z^!UDU@" ;)/8[*W' F2/*NDN$4]X>&9JBW?P)^__2]Y_!ZU;
M:O_!N$^F.N ?^4K":RP,&5AI/UQ335XD&7,R![*&C?3BQSTV!']BP.\F!U^I
M("GT,3I/\4Z,<^Y>)&(4YANXD-Z3K[HD!Z=J2DX:2-$8_1:N&@V[L&7*-;0C
M.%\P$=.RR>4T^;QC/4!D4D6'KZGJ:$CHD_!+'U3ER:_%GL'IZ50YW@77000#
M]PHBN.2\/T57>_U8Z-\*6_X4R/]2($\JQ(UW+WU1ZGESD<^LI^!=4$RK#47R
M.E HEI<-!S\+.$W%0A?PXW6N# ;+J5.*Q87M6)3EB2T1Z9*;+\7865DH#@4X
M#*\1,^.]1BSN/02>YG*8I1TBH5Q[$K8%( ^!))R?LLV<D?#5RK&_GV)_>D0;
M?HMP;8M:!)7/#&@WC6%<=RG>@-(.M,-,XEJ0?FQ#M*1(3R(^PA"^"F=*'AVW
MJ:G_,$Q_][N[J6><C''^>*$/'_O<!H);,DYX*E.8.K".;"/D8=RFK'+5<(6I
M$R^*.'5HLZT(V^V<\S#1K$)LY\I3P%[ #2AMS3+*H7D;J.K?Z)E&X#V7G+E)
M(3..D3OKZ32(.Z>M ,) :P4\C>='7(R'T(C>@I3-FDN8^7&Y6BS><#T*R;J$
M1:"*:XO!<!<ME)/J):>-G^%T22AA,Y:F<+92,;'8\VHS.B4%YX-@!XTG=7W;
MZ&+=3%S;R8,FB+9GR]I.RV6N*BWCRD2A-;^)UB?2JI630BO6#AZL6Y*>:EOH
M'&1'Y++TNB,0)^&(2G*56L#.B1M\D)1%\*(D1B_;[ )MF?(.@Y1WL, !2)6Z
M!(E],\Z;((TB.FE#=:@V!43W";.EL[K0OLK(G>*$ GX#*X*NP1<XXN5R@+!K
MJOH' #WDE.1A#0Q6P")J8 UA#ER(=?M,)%O'ILA>PE-0)1CE5A'=ATK*LT/Z
M<6=*ME<2;DI<$UI0=T%R3RA!;<3I3)/04P9^*)Z#!Y6%E&O3I8XR,8?9";>Y
M?GL[!Z/)[N]\C^C^% 0"?(ZC!IZ0HU'WGBX6B^$5W3+>< @\N5O?@,B<42DJ
M&G/1<$CR,9'HS8<@R,=$@!?:7*KB_(Z=QDXP/B92G!O";J#VW=/B>DS^[P#H
M1M-2F]P^8H\7;L>-;4QM_])JBAQ[6S;A^I1W=#?%_V=N%;%-U6 ,VWHYD!.@
MYY$L%W+I-[JHWG?#U4=E?;:[T[ A"^F*P0M$!.0<7 1$#US[^_ GWF[D3^ 9
M^^Z4,9:'J>2B%@59W)(0"W=A)DU_++PS# UPO<G-GE!P1"692:)!F6BPFL$V
M]H9WU/]0-H7*Q+B)ZU ,5FJX[.RQ9_VQDJ.621,:IU(YD/4>OA;<+I.R&O#)
M8_V9O*MW%+3C[AM'<FJ*P[8UJ55[0MN-0.M2[BWK34_^!?S.C8):UC9!T3E[
M2R^OMP$IB$'%A6BZQUI%-%M%R[V(%URC"E<60V$;8F\(GV]5RNQ6H$$QAYRU
M!4G>A]UUCIIZ:V B.Z9=J!,IRS?+\45S^6ES9RQ2ZK!L9_=C[YY?3'-B;5&U
M@0;OU;K_GZ_(FES]+^*D-A2/@7X_>D^/8M+B>B:"1C2N96!<#+3FTF:<V8G\
MA$=N[TGIYO,75HZ>V%"E56K3U3*M*WQ;FJ7L0E?/;9_9IBPV'[85X<WG4=HW
MG_K9MC56+0WM"^Y-2)EEK,25:U8;; >A"[ 5M^@O)W)2MJ]2TB2R40;E!Z?G
ME!2Z4'GC8'P@NR_P:QJY\DH1Q\5)Y-GH\>.#X58?82SS2P@LK/<@H=Z$?X[?
M+P;&2OXM]R8X&D,JN._(- C?*9:4WC=5'?69E:C+6B%\E 6K9<D-T&V%O@T3
MB8F4L(#JLCXIE^KP&YB*&-P4Q)W&.>ZWME"X!'1C:KHFD/:!&FNFFK30UFVG
M@3)S[:RATV0M4O9B:>Y%L;6%EG;H;9WO"73[!-'/&.JH*#O"M2B$\MAO*+Y:
MDB!H)Z!Z6#V[C8#:S&TY5^+2V(7A31H3/X,JESX]R94CQ6'I&:M<4GH"6RQ3
MLH_R-H1A20D+51-L4FN#=GE383NL0%D6&6(6S^8@7)>>9AK$?-]<.NXR;>_(
M4W)2(1%W7>,6!C4K ,C6<XVNK=<FJFI3P(J[Y1I>] G/W1=Z,@&)V]0BI?6=
MK7 ,2K(FO8P1*N4%JAKDYX2';_+9+63.WFU$&8T[3.OZ3>F01J7^B?3>3/MV
M#:>>0"_[QF![;L:ZM919!  UP<)TP,5,L72MV11F5B(C'Z6MA+6E3NJAJ4-K
MZB3;0!5B^U2G!VL2K]E\ESHRB9T:D(S2*T3%FBCJ?/]^]!<,I1IX@#XUF?2&
M;%N)$S4DIB +*25;0P!+TEK<O#5OXS5#>-URQA7H.FJ]T,-)<W4%,&@SD53^
M+UPS33UF.@D7L+&$0P2]ARAW,IOVQ>K8,\!D\'B0596EB@)-NJR((,FF0[%5
MH"1=/SU^]V6'[SG_WS@F. A%/5Y3'1.*4%/6@;[/%\5G3*:;!$X5+:;ZZ&BU
M747:LV VQ*0H]"XZ0XZL$WE6LDE=1*0U1+E2X@B0^D9MB,#M]F(H3HJ(TP0;
M'<#U\DK)@UTY3-&C89^Z4\\.SFF=3""Z-;;2>=87?VI*FY)K9=T2D$Y]BJP!
M-*%C(TEEM@7:F9X5M5H!CO)4!FA)/K&L[AO5C@G$BKWF'C(P:J7>/EQV93FH
M>*<G.B(9:4/R2U[1J.=Q5-\S2:__+@WB3;K%9UX\TSYOV$OA(2<F9HV)4,\[
M'#MM[2*/>960%T->M@3L]O&M!][:Y,^PIB%U>*6H $7\?4[.RFAG\%V7#.=V
MC-B=\4S!6Z62_-Z(NW3W4L=G,TY=V6U_%G0X+NG[:_Z8?42.#R6ZP5'<BM&&
M;MISX.A:9U?YC&L:IU0]B7SX_.+L](N[QX4(J.07M]%G[!-NS1PDTKJ:<# :
M2VZ/4M%FD.DSX&5AHT/![BAA.);)MF##4/QB&UX9"\ D0!ZY;$1HDN("UH,>
MW<Y.LUXUAUR0Q6((:1M"*9F46_*V6>I7+%9"'L,0KWKJ>H.+](YH^@;$6_FQ
M:W#4'1R7;#Q70E) 1%8J?KZ^G"FX6;ND/LS62V3RK+G&CJ$9:$P;9!ON%.//
M-7]H*"Z:,07+=!Z*=NVX3,&$%YS<(U\4\1V?N90+;@@%=TD0^'V0EVIC)M^-
MVR7YQ8WXW3DI7(R*YVS;[]9J UO<:G)_F&L+[17G0J.'P )W^ZYTTPU/L\UP
MS*-WEU9CA606]\W@4%#;;^<-<=](1T)"IR"CJ;E!G*Y#>J= !9FK.7SG<^YE
MM^06]4S7ZF$GLU[$B)0--RP*EFI*#C)A%%S'C2CI-\GW[UQ0_[@+\2UIR98%
MR,$='69[XOJD+#7T5;Q6-_UYT=V<XT(9#9+\0^>485">/8JL$T/8UU*NXN_3
M%O[96'4P=3WU>I=7D NU_/3^P_WC&TIV_Y^E@2_CGVA_R7\:_B]02P,$%
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M5%<3V9*0BC:RW<9)8@0E6DNV7&NX-K)<0476C9X&:_YS31I6,2B-Y@U850\
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MLLW;V[>PSINV=F7[F]O"BL7$@4M-)(1 1$9QT\BRKHUD+!5*:IK$*+Q#4F=
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M;2TUXX .BIT!V/'F' "\:V ]77YF%U3W_?,GN\O=2_>?A,^?_ =02P,$%
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M/W^^A@)AV^DE"*KUB0\BJ XT.B[KTV]CH_&Z/P@?7(RTBO/K5%Y-B!(\EL2
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M12>!Y-;>7C&Q^Q0^@L8.>NX)"=\H FMT/.GBIBV8#MXSPA&Q5B-.J4<NJ8A
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M3TUTO+:3P?%B^4!3&-^G5\_N?L@O^2^PKY[]#U!+ 0(4 Q0    ( #4Z*EK
M#-#\CP\  "$^   >              "  0    !P<F5S<W)E;&5A<V5I<W-U
M961B>7AE<FES8BYH=&U02P$"% ,4    "  U.BI:443;_:L/  !T<   $0
M            @ '+#P  >&5R<RTR,#(U,#$Q,"YH=&U02P$"% ,4    "  U
M.BI:_H1>A6X"  #T!P  $0              @ &E'P  >&5R<RTR,#(U,#$Q
M,"YX<V102P$"% ,4    "  U.BI:0;P^2>$'  !$.@  %0
M@ %"(@  >&5R<RTR,#(U,#$Q,%]D968N>&UL4$L! A0#%     @ -3HJ6H_G
MZYRB"P  /F8  !4              ( !5BH  'AE<G,M,C R-3 Q,3!?;&%B
M+GAM;%!+ 0(4 Q0    ( #4Z*EJ;6BL%G@<  -(\   5              "
M 2LV  !X97)S+3(P,C4P,3$P7W!R92YX;6Q02P4&      8 !@"3 0  _#T
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>xers-20250110_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xers-20250110.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001867096</identifier>
        </entity>
        <period>
            <startDate>2025-01-10</startDate>
            <endDate>2025-01-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001867096</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-01-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">XERIS BIOPHARMA HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-40880</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">87-1082097</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1375 West Fulton Street,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 1300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">60607</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">445-5704</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">XERS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
